Economy

American Century Companies Inc. Purchases 122703 Shares of Alexion Pharmaceuticals, Inc. (ALXN)

Alexion Pharmaceuticals's quarterly revenue was up 19.9% on a year-over-year basis. (NASDAQ:ALXN) by 1.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).

While under theory that management are shareholders, many value investors look for stocks with a high percent of insider ownership, because they will act in its own self interest, as well create shareholder value in the long-term. American Century Companies Inc. owned about 0.41% of Alexion Pharmaceuticals worth $129,077,000 as of its most recent filing with the SEC.

Institutional investors have also been busy with the stock. Ltd. now owns 33,301 shares of the biopharmaceutical company's stock valued at $4,672,000 after buying an additional 995 shares during the last quarter. Bellwether Investment Group LLC bought a new position in shares of Alexion Pharmaceuticals during the second quarter worth about $172,000. On the opposite side of that transaction from Fmr Llc stood Price T Rowe Associates Inc /md/ which added 3.53 million shares to its existing stake, bringing total stake held in ALXN to 22.82 million shares. Assenagon Asset Management S.A. grew its stake in shares of Alexion Pharmaceuticals by 4,509.0% during the third quarter. The transaction change kept by insiders has seen a change of -41.05% in last six month period.

In terms of performance, shares of AvalonBay Communities, Inc. Ameriprise Financial Inc. now owns 6,175,296 shares of the biopharmaceutical company's stock worth $751,363,000 after purchasing an additional 25,724 shares in the last quarter. Finally, TIAA CREF Investment Management LLC increased its holdings in Alexion Pharmaceuticals by 42.2% in the 2nd quarter. BidaskClub lowered Alexion Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research report on Monday, August 14th. In order to determine directional movement, the 50-day and 200-day moving averages for Alexion Pharmaceuticals, Inc. Leerink Swann reaffirmed an "outperform" rating and set a $211.00 price target on shares of Alexion Pharmaceuticals in a report on Wednesday, November 30th. They noted that the move was a valuation call. Finally, Stifel Nicolaus reduced their target price on shares of Alexion Pharmaceuticals from $165.00 to $159.00 and set a "buy" rating for the company in a report on Tuesday, October 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. The stock was sold at an average price of $140.00, for a total transaction of $1,562,400.00. The stock appeared $149.34 above its 52-week highs and is down -0.58% for the last five trades. (NASDAQ:ODP) reached at $3.01 price level during last trade its distance from 20 days simple moving average is -14.66%, and its distance from 50 days simple moving average is -24.61% while it has a distance of -36.35% from the 200 days simple moving average. The company saw 2.2 million shares trade hands over the course of the day.

Alexion Pharmaceuticals, Inc., a United States of America based Company, belongs to Healthcare sector and Biotechnology industry.

Alexion Pharmaceuticals (NASDAQ:ALXN) last posted its quarterly earnings results on Thursday, October 26th. The biopharmaceutical company reported $1.44 EPS for the quarter, topping the Zacks' consensus estimate of $1.32 by $0.12. Alexion Pharmaceuticals had a return on equity of 10.58% and a net margin of 12.46%. The firm had revenue of $859.00 million during the quarter, compared to analyst estimates of $864.34 million. During the same quarter past year, the business posted $1.23 EPS. This company shares are 329.98% off its target price of $17.5 and the current market capitalization stands at $122.12M. Also, EVP Julie O'neill sold 11,160 shares of Alexion Pharmaceuticals stock in a transaction dated Monday, August 28th. Following the completion of the transaction, the director now directly owns 5,480 shares of the company's stock, valued at approximately $799,038.80. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The stock is pricing at $115.39 after moving -1.73% from the opening bell. Cornerstone Advisors Inc. now owns 964 shares of the biopharmaceutical company's stock worth $118,000 after buying an additional 310 shares during the last quarter. The disclosure for this sale can be found here. The share price was last seen -1.45% lower, reaching at $4.07 on November 08, 2017.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States & global copyright & trademark laws. The original version of this news story can be accessed at https://www.truebluetribune.com/2017/11/09/american-century-companies-inc-purchases-122703-shares-of-alexion-pharmaceuticals-inc-alxn.html.

NovaGold Resources Inc., a Canada based Company, belongs to Basic Materials sector and Gold industry.

Investigating the productivity proportions of The Boeing Company, (NYSE: BA) stock, speculator will discover its ROE, ROA, ROI remaining at 0%, 7.4% and 0%, individually. The Company's marketed products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous).



Like this

Latest


09 November 2017
Oasis Petroleum Inc. (OAS) Issues Earnings Results, Beats Estimates By $0.04 EPS
MARSHALL WACE ASIA Ltd acquired a new stake in shares of Oasis Petroleum during the 1st quarter worth approximately $1,258,000. The energy producer reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.04, reports.

09 November 2017
OPP identify victims from yesterday's crash on Hwy 17
Investigators are appealing to any witnesses who have not yet spoken to police to come forward and contact the Aurora OPP. Provincial police have identified the second of three people killed in that fiery crash on Highway 400 last Tuesday.

09 November 2017
Andrea Pirlo thanks fans for response after retirement announcement
So, can we perhaps expect to see Pirlo and Gattuso cross paths as a pair of managers in the not too distant future? The 39-year-old had a wonderfully self deprecating response when the question was posed to him on Radio 24 .

09 November 2017
The MSI Financial Services Inc Reduces Stake in General Mills Inc. (GIS)
Los Angeles Capital Mgmt & Equity invested in 0.17% or 488,866 shares. (NYSE:GIS). 155,264 were accumulated by Huntington Bancorp. Williams Jones & Associates LLC's holdings in General Mills were worth $8,957,000 at the end of the most recent reporting period.

09 November 2017
LaPorte boy takes auto for joyride
The Rio then fishtailed on a state highway before spinning out and crashing into metal fence outside of a business. The auto pulled onto Lincolnway without stopping to see if there was any oncoming traffic.

09 November 2017
Brooks Automation, Inc. Earnings Ahead: Quick Glance
University Of Texas Investment Managment Co holds 4.33% of its portfolio in Bio-Path Holdings Inc for 3.83 million shares. The Firm operates through two divisions: Brooks Semiconductor Solutions Group and Brooks Life Science Systems.

09 November 2017
Sturgill Simpson stages own concert outside CMA Awards
Come on down and join me! Sturgill played songs right in front of the arena entrance, and streamed the performance on Facebook . He announced the appearance a short time before on Facebook "So excited to be playing the #cmaawards tonight!" he wrote.

09 November 2017
Gilead Sciences, Inc. (NASDAQ:GILD) Analysts See 13.5%
Gilead Sciences, Inc. (GILD ) now has 1.31 million shares outstanding, which means that its market capitalization is $95.92B. Excalibur Management Corp has invested 1.45% in Gilead Sciences, Inc . 12,681 were accumulated by Cim Mangement Inc.

09 November 2017
The Dollar General Corp. (DG) to Issue $0.25 Quarterly Dividend
Fic Capital Inc increased its stake in Facebook Inc Cl A (FB) by 19.54% based on its latest 2017Q2 regulatory filing with the SEC. Several institutional investors have recently modified their holdings of DG. 71 funds opened positions while 178 raised stakes.

09 November 2017
Understanding the Financial Health of American Axle & Manufacturing Holdings, Inc. (NYSE:AXL)
The expected future growth in earnings per share ("EPS") is an incredibly important factor.in identifying an under-valued stock. To see more absolute value, taking notice on its price to next year's EPS that cloud be 11.72%, according to Thomson Reuter.



Recommended